ID

16897

Descrizione

Clozapine and Olanzapine Treatment of Aggression; ODM derived from: https://clinicaltrials.gov/show/NCT01123408

collegamento

https://clinicaltrials.gov/show/NCT01123408

Keywords

versioni (1)
  1. 13/08/16 13/08/16 -
Caricato su

13 agosto 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Schizophrenia NCT01123408

Inglese

Eligibility Schizophrenia NCT01123408

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: 18 to 60 years.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of schizophrenia or schizoaffective disorder.
Descrizione

Schizophrenia or schizoaffective disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036337
aggression: one episode of physical assault directed at another person in the hospital and persistence of violence/hostility for two weeks, as evidenced by the presence of some other physical, verbal or property assault or hostility, which would result in a score of 4 or more on the positive and negative syndrome scale (panss) hostility item.
Descrizione

Aggression and PANSS

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001807
UMLS CUI [2]
C0451383
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who were hospitalized for more than a year
Descrizione

Hospitalization

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019993
patients who had a history of nonresponse to clozapine, olanzapine or haloperidol (defined as a lack of improvement despite a contiguous adequate trial of medication)
Descrizione

Nonresponse to clozapine, olanzapine or haloperidol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3845351
UMLS CUI [1,2]
C0009079
UMLS CUI [2,1]
C3845351
UMLS CUI [2,2]
C0171023
UMLS CUI [3,1]
C3845351
UMLS CUI [3,2]
C0018546
patients who had a history of clozapine, olanzapine, or haloperidol intolerance
Descrizione

Intolerance to clozapine, olanzapine, or haloperidol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0009079
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0171023
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0018546
patients who had medical conditions that would be adversely affected by any of these three medications.
Descrizione

Comorbidity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
patients who received a depot antipsychotic within 30 days before randomization.
Descrizione

Depot antipsychotic medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2585377
Ritorna all'inizio della pagina

Similar models

Eligibility Schizophrenia NCT01123408

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: 18 to 60 years.
boolean
C0001779 (UMLS CUI [1])
Schizophrenia or schizoaffective disorder
Item
diagnosis of schizophrenia or schizoaffective disorder.
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Aggression and PANSS
Item
aggression: one episode of physical assault directed at another person in the hospital and persistence of violence/hostility for two weeks, as evidenced by the presence of some other physical, verbal or property assault or hostility, which would result in a score of 4 or more on the positive and negative syndrome scale (panss) hostility item.
boolean
C0001807 (UMLS CUI [1])
C0451383 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hospitalization
Item
patients who were hospitalized for more than a year
boolean
C0019993 (UMLS CUI [1])
Nonresponse to clozapine, olanzapine or haloperidol
Item
patients who had a history of nonresponse to clozapine, olanzapine or haloperidol (defined as a lack of improvement despite a contiguous adequate trial of medication)
boolean
C3845351 (UMLS CUI [1,1])
C0009079 (UMLS CUI [1,2])
C3845351 (UMLS CUI [2,1])
C0171023 (UMLS CUI [2,2])
C3845351 (UMLS CUI [3,1])
C0018546 (UMLS CUI [3,2])
Intolerance to clozapine, olanzapine, or haloperidol
Item
patients who had a history of clozapine, olanzapine, or haloperidol intolerance
boolean
C1744706 (UMLS CUI [1,1])
C0009079 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0171023 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0018546 (UMLS CUI [3,2])
Comorbidity
Item
patients who had medical conditions that would be adversely affected by any of these three medications.
boolean
C0009488 (UMLS CUI [1])
Depot antipsychotic medication
Item
patients who received a depot antipsychotic within 30 days before randomization.
boolean
C2585377 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial